South Warwickshire Anaesthetic Services Limited iXBRL

South Warwickshire Anaesthetic Services Limited

Directors' Report and Unaudited Financial Statements

for the financial year ended 31 March 2025

South Warwickshire Anaesthetic Services Limited

DIRECTORS AND OTHER INFORMATION


Directors	Mr Paul Jefferson
	Mrs Izabela Jefferson


Company Registration Number	08728392


Registered Office	Cuckoo Wharf
	427 Lichfield Road
	Birmingham
	B6 7SS
	United Kingdom


Business Address	Grey Gable
	Langley Road
	Warwick
	CV35 8PU
	United Kingdom


Accountants	Capitax & Co (Tax Consultants) Ltd
	Cuckoo Wharf
	427 Lichfield Road
	Birmingham
	West Midlands
	B6 7SS
	GB

South Warwickshire Anaesthetic Services Limited

DIRECTORS' REPORT

for the financial year ended 31 March 2025

The directors present their report and the unaudited financial statements for the financial year ended 31 March 2025.

Principal Activity

Specialist medical services

Directors

The directors who served during the financial year are as follows:

Mr Paul Jefferson

Mrs Izabela Jefferson

There were no changes in shareholdings between 31 March 2025 and the date of signing the financial statements.

In accordance with the Constitution, the directors retire by rotation and, being eligible, offer themselves for re-election.

Political Contributions

The company did not make any disclosable political donations in the current financial year.

Statement of Directors' Responsibilities

The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland". Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

▪

select suitable accounting policies and apply them consistently;

▪

make judgements and accounting estimates that are reasonable and prudent;

▪

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Special provisions relating to small companies

The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

On behalf of the board

___________________________

Mr Paul Jefferson

Director

28 November 2025

South Warwickshire Anaesthetic Services Limited

PROFIT AND LOSS ACCOUNT

for the financial year ended 31 March 2025

	2025	2024
Notes	£	£

Turnover		154,688	97,145
		─────────	─────────
Gross profit		154,688	97,145

Administrative expenses		(36,427)	(27,713)
		─────────	─────────
Operating profit		118,261	69,432

Interest receivable and similar income	3	9,761	2,002
		─────────	─────────
Profit before taxation		128,022	71,434

Tax on profit	5	(30,176)	(15,180)
		─────────	─────────
Profit for the financial year		97,846	56,254
		─────────	─────────
Total comprehensive income		97,846	56,254
		═════════	═════════

South Warwickshire Anaesthetic Services Limited

Company Registration Number: 08728392

BALANCE SHEET

as at 31 March 2025

		2025	2024
	Notes	£	£

Current Assets

Debtors

84,857

18,945

Cash and cash equivalents

253,100

207,532

─────────

337,957

226,477

─────────

Creditors: amounts falling due within one year

(31,606)

(17,033)

─────────

Net Current Assets

306,351

209,444

─────────

Total Assets less Current Liabilities

306,351

209,444

Creditors:

amounts falling due after more than one year

(4,895)

(4,584)

─────────

Net Assets

301,456

204,860

═════════

Capital and Reserves

Called up share capital

100

100

Retained earnings

301,356

204,760

─────────

Equity attributable to owners of the company

301,456

204,860

═════════

These financial statements have been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Board and authorised for issue on 28 November 2025 and signed on its behalf by



________________________________
Mr Paul Jefferson
Director

South Warwickshire Anaesthetic Services Limited

NOTES TO THE FINANCIAL STATEMENTS

for the financial year ended 31 March 2025

General Information

South Warwickshire Anaesthetic Services Limited is a company limited by shares incorporated and registered in the United Kingdom. The registered number of the company is 08728392. The registered office of the company is Cuckoo Wharf, 427 Lichfield Road, Birmingham, B6 7SS, United Kingdom. Specialist medical services The financial statements have been presented in Pound (£) which is also the functional currency of the company.

Summary of Significant Accounting Policies

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.

Statement of compliance

The financial statements of the company for the financial year ended 31 March 2025 have been prepared in accordance with the Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland (FRS 102) issued by the Financial Reporting Council and in accordance with the Companies Act 2006.

Basis of preparation

The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.

Cash flow statement

The company has availed of the exemption in FRS 102 from the requirement to prepare a Statement of Cash Flows because it is classified as a small company.

Turnover

Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Borrowing costs

Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Employee benefits

The company operates a salary sacrifice pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund.

Taxation and deferred taxation

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements.

Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.

Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.

Ordinary share capital

The ordinary share capital of the company is presented as equity.


3.	Interest receivable and similar income	2025	2024
		£	£

	Bank interest	9,761	2,002
		═════════	═════════

Employees

The average monthly number of employees, including directors, during the financial year was 1, (2024 - 1).

2025

2024

Number

Number

Directors

═════════

Tax on profit

2025

2024

(a) Analysis of charge in the financial year

Current tax:

Corporation tax at 25.00% (2024 - 25.00%) (Note 5 (b))

30,176

15,180

═════════

(b) Factors affecting tax charge for the financial year

The tax assessed for the financial year differs from the standard rate of corporation tax in United Kingdom 25.00% (2024 - 25.00%). The differences are explained below:

2025

2024

Profit taxable at 25.00%

128,022

71,434

═════════

Profit before tax

multiplied by the standard rate of corporation tax

in United Kingdom at 25.00% (2024 - 25.00%)

32,006

17,859

Effects of:

Marginal Tax Relief

(1,830)

(2,679)

─────────

Total tax charge for the financial year (Note 5 (a))

30,176

15,180

═════════


6.	Debtors	2025	2024
		£	£

	Debtors	84,857	18,945
		═════════	═════════


7.	Creditors	2025	2024
	Amounts falling due within one year	£	£

	Taxation (Note 9)	30,376	15,180
	Other creditors	-	625
	Accruals	1,230	1,228
		─────────	─────────
		31,606	17,033
		═════════	═════════


8.	Creditors	2025	2024
	Amounts falling due after more than one year	£	£

	Directors' loan accounts	4,895	4,584
		═════════	═════════


9.	Taxation	2025	2024
		£	£

	Creditors:
	Corporation tax	30,176	15,180
	PAYE / NI	200	-
		─────────	─────────
		30,376	15,180
		═════════	═════════

10.

Capital commitments

The company had no material capital commitments at the financial year-ended 31 March 2025.

11.

Directors' advances, credits and guarantees

During the financial year, the company made no loan(s) to Director(s).

12.

Post-Balance Sheet Events

There have been no significant events affecting the company since the financial year-end.